What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Bacteria
- Enzyme
His primary scientific interests are in Microbiology, Virulence, Internal medicine, Caenorhabditis elegans and Cryptococcus neoformans.
His Microbiology study combines topics from a wide range of disciplines, such as Galleria mellonella, Innate immune system and Fungal protein.
His Virulence research incorporates elements of Wild type, Mutant, Host and Staphylococcus aureus.
His work deals with themes such as Gastroenterology, Surgery and Immunology, which intersect with Internal medicine.
His study in Caenorhabditis elegans is interdisciplinary in nature, drawing from both Enterococcus faecalis and Yeast.
His Meta-analysis research integrates issues from Colonization, Intensive care medicine, Confidence interval, Complication and Pediatrics.
His most cited work include:
- Infective endocarditis in adults. (1045 citations)
- Google Trends: A Web-Based Tool for Real-Time Surveillance of Disease Outbreaks (490 citations)
- A simple model host for identifying Gram-positive virulence factors (457 citations)
What are the main themes of his work throughout his whole career to date?
Eleftherios Mylonakis focuses on Microbiology, Internal medicine, Virulence, Candida albicans and Antimicrobial.
His Microbiology research is multidisciplinary, incorporating elements of Galleria mellonella, Caenorhabditis elegans, In vivo and Staphylococcus aureus.
The various areas that he examines in his Caenorhabditis elegans study include Innate immune system and Cell biology.
The study incorporates disciplines such as Gastroenterology, Surgery and Intensive care medicine in addition to Internal medicine.
Cryptococcus and Cryptococcosis is closely connected to Cryptococcus neoformans in his research, which is encompassed under the umbrella topic of Virulence.
His Candida albicans study integrates concerns from other disciplines, such as Fluconazole and Biofilm.
He most often published in these fields:
- Microbiology (41.83%)
- Internal medicine (25.05%)
- Virulence (16.35%)
What were the highlights of his more recent work (between 2017-2021)?
- Microbiology (41.83%)
- Internal medicine (25.05%)
- Antibiotics (11.25%)
In recent papers he was focusing on the following fields of study:
Eleftherios Mylonakis spends much of his time researching Microbiology, Internal medicine, Antibiotics, Staphylococcus aureus and Antimicrobial.
His Microbiology study combines topics in areas such as In vivo, Virulence and Biofilm.
His research integrates issues of Caenorhabditis elegans and Immune system in his study of Virulence.
His study in Antibiotics is interdisciplinary in nature, drawing from both Vancomycin, Lipid bilayer, Methicillin-resistant Staphylococcus aureus and High-throughput screening.
His Staphylococcus aureus research is multidisciplinary, relying on both Enterococcus faecium, Minimum inhibitory concentration and Antimicrobial stewardship, Antibiotic resistance.
His work carried out in the field of Antimicrobial brings together such families of science as Auranofin, Gentamicin and Pharmacology.
Between 2017 and 2021, his most popular works were:
- Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. (150 citations)
- A new class of synthetic retinoid antibiotics effective against bacterial persisters (139 citations)
- The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications (58 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Bacteria
- Enzyme
His scientific interests lie mostly in Internal medicine, Microbiology, Antibiotics, Staphylococcus aureus and Antimicrobial.
His Internal medicine research includes elements of Antimicrobial stewardship and Blood culture.
His biological study spans a wide range of topics, including In vivo and Biofilm.
Eleftherios Mylonakis interconnects Lipid bilayer, Cytotoxicity and Bacteria in the investigation of issues within Antibiotics.
His research in Staphylococcus aureus intersects with topics in Cancer cell, Pathogen and Secondary infection.
His Hypha research incorporates elements of Nematode, Caenorhabditis elegans, Lactobacillus and Virulence.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
